Aminothiazole-based inhibitors designed for HCV polymerase display low micromolar potencies in biochemical assays. These compounds show a stringent preference for a cyclohexyl hydrophobe at the 2-amino position. The composition of these compounds suggests that they may be interacting at a recently discovered allosteric site on the polymerase. (C) 2004 Elsevier Ltd. All rights reserved.
作者:Gerald W. Shipps、Yongqi Deng、Tong Wang、Janeta Popovici-Muller、Patrick J. Curran、Kristin E. Rosner、Alan B. Cooper、Viyyoor Girijavallabhan、Nancy Butkiewicz、Michael Cable
DOI:10.1016/j.bmcl.2004.10.024
日期:2005.1
Aminothiazole-based inhibitors designed for HCV polymerase display low micromolar potencies in biochemical assays. These compounds show a stringent preference for a cyclohexyl hydrophobe at the 2-amino position. The composition of these compounds suggests that they may be interacting at a recently discovered allosteric site on the polymerase. (C) 2004 Elsevier Ltd. All rights reserved.